raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:98933

Multiple system atrophy, parkinsonian type

Synonyms: MSA, parkinsonian type · MSA-p

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
Not applicable
Age of onset
Adult
Status
active

Multiple system atrophy, parkinsonian type (MSA-p) is a form of multiple system atrophy (MSA) with predominant parkinsonian features (bradykinesia, rigidity, irregular jerky postural tremor, and postural instability).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMultiple system atrophy, parkinsonian typeMSA, parkinsonian type · MSA-p
frAtrophie multisystématisée type parkinsonienAMS type parkinsonien · AMS-p · Atrophie multisystémique type parkinsonien
deMultisystematrophie vom Typ ParkinsonMSA vom Parkinsontyp · MSA-P
esAtrofia multisistémica tipo parkinsonianoASM tipo parkinsoniano · ASM-p
itAtrofia multisistemica, tipo parkinsonianoMSA, tipo parkinsoniano · MSA-p
nlMeervoudige systeematrofie, parkinsoniaans typeMSA, parkinsoniaans type · MSA-p
ptDegeneração estriatonígrica
plZanik wieloukładowy, typ parkinsonowskiMSA, typ parkinsonowski · MSA-p
csMnohočetná systémová atrofie parkinsonského typuMSA parkinsonského typu · MSA-p
ukМножинна системна атрофія, паркінсонічний типMSA, паркінсонічний тип · MSA-p
zh多系统萎缩帕金森型MAS帕金森型
trMulti sistem atrofisi, parkinson tipiMSA-p · MSA, parkinson tipi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10G23.2Especificvalidated
ICD-118D87.01Especificvalidated
MONDO0020352Evalidated
UMLSC5554235Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
COQ2Major susceptibility factor inAssessedHGNC:25223ENSG000001730856098254q21.23coenzyme Q2, polyprenyltransferase23758206[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0002.4 / 100 000EuropeValue and classNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

30 annotations · validated 2018-03-12
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0012332Abnormal autonomic nervous system physiology
HP:0012658Abnormal brain FDG positron emission tomography
HP:0007256Abnormal pyramidal signDiagnostic criterion
HP:0002494Abnormal rapid eye movement sleep
HP:0000739Anxiety
HP:0000741Apathy
HP:0005341Autonomic bladder dysfunctionDiagnostic criterion
HP:0008652Autonomic erectile dysfunction
HP:0002530Axial dystonia
HP:0002067Bradykinesia
HP:0010536Central sleep apnea
HP:0002019Constipation
HP:0000716Depression
HP:0030015Female anorgasmia
HP:0002359Frequent falls
HP:0002310Orofacial dyskinesia
HP:0004926Orthostatic hypotension due to autonomic dysfunctionDiagnostic criterion
HP:0012670Orthostatic syncope
HP:0001300ParkinsonismDiagnostic criterion
HP:0002172Postural instability
HP:0030880Raynaud phenomenon
HP:0002322Resting tremor
HP:0002063Rigidity
HP:0010307StridorDiagnostic criterion
Occasional (29-5%)
HP:0100595Camptocormia
HP:0001260Dysarthria
HP:0002066Gait ataxia
HP:0000640Gaze-evoked nystagmus
HP:0002174Postural tremor
HP:0002073Progressive cerebellar ataxiaDiagnostic criterion

Annotation source: 18725592[PMID]_14747001[PMID]_23758206[PMID]_14219099[PMID]_14446364[PMID]

7

Sources for this card